Vincent Brichard

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Vincent Brichard, Aline Van Pel, Thomas Wölfel et al. · The Journal of Experimental Medicine · 1993 · 959 citations · Full text

Life Sciences, Immunology, Oncology +17

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Pierre G. Coulie, Vincent Brichard, Aline Van Pel et al. · The Journal of Experimental Medicine · 1994 · 916 citations · Full text

Life Sciences, Genetics, Immunology +17

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

Marie Marchand, Nicolas van Baren, P. Weynants et al. · International Journal of Cancer · 1999 · 786 citations

Life Sciences, Immunology, Oncology +17

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

Johan Vansteenkiste, Byoung Chul Cho, Tõnu Vanakesa et al. · The Lancet Oncology · 2016 · 497 citations · Full text

Medicine, Immunology, Oncology +16

Predictive Gene Signature in MAGE-A3 Antigen-Specific Cancer Immunotherapy

Fernando Ulloa‐Montoya, Jamila Louahed, Benjamin Dizier et al. · Journal of Clinical Oncology · 2013 · 475 citations · Full text

Medicine, Immunology, Oncology +17